SCHEMBL7962133

SCHEMBL7962133

CCn1ncc2c(NCc3ccc(OC)c(Cl)c3)c(C(=O)NC3CCN(Cc4ccccc4)CC3)cnc21

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 7/20 0.69
MCHR1 Q99705 1/20 0.53
DRD2 P14416 2/20 0.51
DRD4 P21917 2/20 0.51
DRD3 P35462 2/20 0.51
CYP3A4 P08684 2/20 0.51
CYP1A2 P05177 1/20 0.51
ADRA2A P08913 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
ADRA2B P18089 1/20 0.51
ADRA2C P18825 1/20 0.51
ACHE P22303 1/20 0.51
SLC6A2 P23975 1/20 0.51
HTR2A P28223 1/20 0.51
HTR2C P28335 1/20 0.51
ADRA1A P35348 1/20 0.51
OPRK1 P41145 1/20 0.51
HTR2B P41595 1/20 0.51
CHRNA4 P43681 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7955102 0.91 PDE5A (0.72) PDE5APDE4B
SCHEMBL7955249 0.88 PDE5A (0.68) PDE5APDE4B
SCHEMBL7959208 0.88 PDE5A (0.71) PDE5APDE4B
SCHEMBL12551683 0.85 PDE5A (0.86) PDE5APDE4B
SCHEMBL7955490 0.82 PDE5A (0.90) PDE5APDE4B
SCHEMBL1082869 0.82 PDE5A (1.00) PDE5APDE4B
SCHEMBL7959091 0.82 PDE5A (0.65) PDE5A
SCHEMBL7167177 0.82 PDE5A (0.66) PDE5AMCHR1DRD2DRD4DRD3
SCHEMBL7954856 0.82 PDE5A (0.71) PDE5APDE4B
SCHEMBL7948019 0.82 PDE5A (0.82) PDE5APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6326379-B1 ERECTILE DYSFUNCTION; CARDIOVASCULAR DISORDERS BRISTOL-MYERS SQUIBB CO. 2001-12-04 US claimed
US-6326379-B1 ERECTILE DYSFUNCTION; CARDIOVASCULAR DISORDERS BRISTOL-MYERS SQUIBB CO. 2001-12-04 US disclosed